Abstract
We have reviewed the effects on adrenergic receptors by membrane phospholipid alterations secondary to oxidative stress and phospholipases' activity. Experimental evidences indicate that the function of both α- and β-adrenoceptors is regulated by their phospholipid microdomain; however, the underlying mechanism is still undefined. No information seems to be available on the influence of phospholipids on β2-adrenoceptors and on all adrenoceptors' subtypes. Thus, further studies are necessary to clarify the role of membrane phospholipids in regulating the function of each member of the adrenergic receptor superfamily.
Similar content being viewed by others
References
Strosberg AD: Structure, function and regulation of adrenergic receptors. Protein Sci 2: 1198–1209, 1993
Ahlquist RP: A study of adrenotropic receptors. Am J Physiol 153: 586–600, 1948
Bylun DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowtiz RJ, Minneman K, Molinoff PB, Ruffolo RR, Trendelenburg V: International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 46: 121–136, 1994
Ford APDW, Williams TJ, Blue DR, Clarke DE: 221-1 classification: Sharpening Occam's razor. Trends Pharmacol Sci 15: 167–170, 1994
Ruffolo RR, Hieble PB: α-Adrenoceptors. Pharmac Ther 61: 1–64, 1994
Exton JH. Phosphoinositide phospholipases and G proteins in hormone action. Annu Rev Physiol 56: 349–369, 1994
Berridge M: Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 220: 345–360, 1984
Tang W-J, Gilman AG: Adenylyl cyclases. Cell 70: 869–872, 1992
Birnbaumer L: G proteins in signal transduction. Annu Rev Pharmacol Toxicol 30: 675–705, 1990
Clapham DE, Neer EJ: New roles for G-proteins βγ-dimers in transmembrane signalling. Nature 365: 403–406, 1993
Sternweis PC: The active role of βγ in signal transduction. Curr Opin Cell Biol 6: 198–203, 1994
Kinsella BT, O'Mahoney DJ: Lipid modification of G proteins. Trends Cardiovasc Med 4: 27–34, 1994
Bernstein G, Blank JL, Jhon D-Y, Exton JH, Rhee SG, Ross EM: Phospholipase C-β2 is a GTPase activating protein for Gq/11, its physiological regulator. Cell 70: 411–418, 1992
Brown AM: Membrane-delimited cell signalling complexes: direct ion channel regulation by G proteins. J Membr Biol 131: 93–104, 1993
Wu D, Simon MI: Identification of critical regions on phospholipase C-β required for activation by G-proteins. J Biol Chem 268: 3704–3709, 1993
Carruthers A, Melchior DL: Effect of lipid environment on membrane transport: the human erythrocyte sugar transport protein/bilayer system. Annu Rev Physiol 50: 257–271, 1988
Halliwell B: Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91(suppl 3C): 14S-22S, 1991
Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK: Free radicals and the heart. J Pharmacol Toxicol Methods 30: 55–67, 1993
Sies H, Cadenas E: Oxidative stress: damage to intact cells and organs. Phil Trans Roy Soc London B 311: 617–631, 1985
Freeman BA, Crapo JD: Biology of disease. Free radicals and tissue injury. Lab Invest 47: 412–426, 1982
Wolff SP, Garner A, Dean RT: Free radicals, lipids and protein degradation. Trends Biochem Sci 11: 27–31, 1986
Haenen GR, Veerman M, Bast A: Reduction of β-adrenoceptor function by oxidative stress in the heart. Free Radical Biol Med 9: 279–288, 1990
McMurchie EJ: Dietary lipids and the regulation of membrane fluidity and function. In: R.C. Aloia, C.C. Curtain, L.M. Gordon (eds). Physiological regulation of membrane fluidity. Alan R. Liss, New York, 1988, pp 189–237
Shinitzky M: Membrane fluidity and cellular functions. In: M. Shinitzky (ed.). Physiology of membrane fluidity, vol. 1. CRC Press, Boca Raton, 1984, pp 1–51
Richter C: Biophysical consequences of lipid peroxidation in membrane. Chem Phys Lipids 44: 175–189, 1987
Hershkowitz M, Heron D, Samuel D, Shinitzky M: Modulation of protein phosphorylation and receptor binding in brain membranes by changes in lipid microviscosity: implication for aging. Prog Brain Res 56: 419–425, 1982
Kaneko M, Panagia V, Paolillo G, Majumder S, Ou C, Dhalla NS: Inhibition of cardiac phosphatidylethanolamine N-methylation by oxygen free-radicals. Biochim Biophys Acta 1021: 33–38, 1990
Meij JTA, Suzuki S, Panagia V, Dhala NS: Oxidative stress modifies the activity of cardiac sarcolemmal phospholipase C. Biochim Biophys Acta 1199: 6–12, 1994
Dai J, Meij JTA, Padua R, Panagia V: Depression of sarcolemmal phospholipase D activity by oxidant-induced thiol modification. Circ Res 71: 970–977, 1992
Limas CJ: Effect of phospholipid methylation on β-adrenergic receptors in the normal and hypertrophied rat myocardium. Circ Res 47: 536–541, 1980
Okumura K, Ogawa K, Sataka T: Phospholipid methylation in canine membranes: relations to β-adrenergic receptors and digitalis receptors. Jpn Heart J 24: 215–225, 1983
Strittmatter WJ, Hirata F, Axelrod J: Phospholipid methylation unmasks cryptic β-adrenergic receptors in rat reticulocytes. Science 204: 1205–1207, 1979
Hirata F: Regulation of membrane fluidity by phospholipid methylation. In: R.C. Aloia, J.M. Boggs (eds.). Membrane fluidity in biology. Academic Press, Orlando, 1985, pp 247–257
Pruijn FB, Van Gelderen H, Bast A: The effects of radical stress and N-ethylmaleimide on rat hepatic α1-adrenergic receptors. Toxicol Lett 45: 73–82, 1989
Vetter R, Dai J, Mesaeli N, Panagia V, Dhalla NS: Role of sulfhydryl groups in phospholipid methylation reactions of cardiac sarcolemma. Mol Cell Biochem 103: 85–96, 1991
Van der Vliet A, Bast A: Effect of oxidative stress on recepotors and signal transmission. Chem-Biol Interactions 85: 95–116, 1992
Waite M: The phospholipases. Handbook of lipid research, vol. 5, Plenum Press, New York, 1988, pp 332
Axelrod J: Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochem Soc Trans 18: 503–507, 1990
Exton JH: Phosphoinositide phospholipases and G protein in hormone action. Annu Rev Physiol 56: 349–369, 1994
Billah MM, Anthes JC: The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J 269: 281–291, 1990
Prasad MR, Popescu LM, Moraru II, Liu X, Maity S, Engelman RM, Das DK. Role of phospholipase A2 and C in myocardial ischemic reperfusion. Am J Physiol 260: H877-H883, 1991
Panagia V, Meij JTA, Mesaeli N, Singal RK, Dhalla NS: Depression of sarcolemmal phospholipase C activity in congestive heart failure. In: N.S. Dhalla, G.N. Pierce, V. Panagia, R.E. Beamish (eds.) Heart hypertrophy and failure. Kluwer Acad. Publ, Boston, in press
Dai J, Panagia V: Distinct changes of sarcolemmal and sarcoplasmic reticular phospholipase D activity in ischemic-reperfused heart. FASEB J 7: A121, 1993
Kirilovsky J, Schramm M: Delipidation of a β-adrenergic receptor preparation and reconstitution by specific lipids. J Biol Chem 258: 6841–6849, 1983
Limbird LE, Lefkowitz RJ: Adenylate cyclase-coupled beta-adrenergic receptors: Effect of membrane lipid-perturbing agents on receptor binding and enzyme stimulation by catecholamines. Mol Pharmacol 12: 559–567, 1976
Shreeve SM, Valliere JE: The α1-adrenoceptor is inactivated by alterations in membrane phosphilipids. Eur J Pharmacol 226: 29–33, 1992
Skúladóttir GV, Schiöth HB, Gudbjarmason S: Polyunsaturated fatty acids in heart muscle and α1-adrenoceptor binding properties. Biochim Biophys Acta 1178: 49–54, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, S., Meij, J.T.A. & Panagia, V. Membrane phospholipids and adrenergic receptor function. Mol Cell Biochem 149, 217–222 (1995). https://doi.org/10.1007/BF01076580
Issue Date:
DOI: https://doi.org/10.1007/BF01076580